Search Results - "KERRE, Tessa"

Refine Results
  1. 1
  2. 2

    Nanobody Based Dual Specific CARs by De Munter, Stijn, Ingels, Joline, Goetgeluk, Glenn, Bonte, Sarah, Pille, Melissa, Weening, Karin, Kerre, Tessa, Abken, Hinrich, Vandekerckhove, Bart

    “…Recent clinical trials have shown that adoptive chimeric antigen receptor (CAR) T cell therapy is a very potent and possibly curative option in the treatment…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data by Roex, Gils, Feys, Tom, Beguin, Yves, Kerre, Tessa, Poiré, Xavier, Lewalle, Philippe, Vandenberghe, Peter, Bron, Dominique, Anguille, Sébastien

    Published in Pharmaceutics (24-02-2020)
    “…Chimeric antigen receptor (CAR)-T-cell therapy is an innovative form of adoptive cell therapy that has revolutionized the treatment of certain hematological…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy by Catanzaro, Elena, Turrini, Eleonora, Kerre, Tessa, Sioen, Simon, Baeyens, Ans, Guerrini, Alessandra, Bellau, Mohamed Lamin Abdi, Sacchetti, Gianni, Paganetto, Guglielmo, Krysko, Dmitri V, Fimognari, Carmela

    Published in Biomedicine & pharmacotherapy (01-10-2022)
    “…Ferroptosis induction is an emerging strategy to treat cancer and contrast the tricky issue of chemoresistance, which can arise towards apoptosis. This work…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Infrared Spectroscopy: A New Frontier in Hematological Disease Diagnosis by Delrue, Charlotte, Speeckaert, Reinhart, Oyaert, Matthijs, Kerre, Tessa, Rottey, Sylvie, Coopman, Renaat, Huvenne, Wouter, De Bruyne, Sander, Speeckaert, Marijn M

    “…Hematological diseases, due to their complex nature and diverse manifestations, pose significant diagnostic challenges in healthcare. The pressing need for…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft- Versus -Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation by Vandenhove, Benoît, Canti, Lorenzo, Schoemans, Hélène, Beguin, Yves, Baron, Frédéric, Graux, Carlos, Kerre, Tessa, Servais, Sophie

    Published in Frontiers in immunology (21-10-2020)
    “…Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy against hematological cancers for more than six decades. Its…”
    Get full text
    Journal Article Web Resource
  17. 17

    Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review by Jolles, Stephen, Giralt, Sergio, Kerre, Tessa, Lazarus, Hillard M, Mustafa, S Shahzad, Ria, Roberto, Vinh, Donald C

    Published in Frontiers in oncology (07-02-2023)
    “…Patients with hematological malignancies (HMs), like chronic lymphocytic leukemia (CLL), multiple myeloma (MM), and non-Hodgkin lymphoma (NHL), have a high…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20